How Quickly Do You Lose Weight on Wegovy?

What does the trial data say about the speed of weight loss?

The clearest picture comes from the STEP 1 trial, published in the New England Journal of Medicine: 68 weeks, 2.4mg semaglutide, versus placebo, in adults living with obesity. Participants lost an average of about 15% of their body weight. That works out at roughly one to two kilogrammes per month across the trial period, though the curve is not flat, loss tends to be slower at first and picks up as the dose increases.

By week 4, many participants had already lost a small but measurable amount, primarily from the appetite-suppressing effect even at the 0.25mg starting dose. By week 20 or so, once most people had reached the 1.7mg dose, the rate of loss was typically at its steepest. Weight loss then continues but gradually plateaus as the body adapts. That plateau is normal biology, not a sign the medicine has stopped working.

It is also worth being honest about variation. Some people in STEP 1 lost considerably more than 15%; others lost less. A trial average tells you what is plausible, not what you personally will experience. Factors including starting BMI, metabolic health, how high a dose you tolerate, and whether you make changes to eating and activity patterns all play a role. Our clinical team reviews every patient's full picture, not just their weight.

How does the titration schedule affect how quickly weight loss starts?

Wegovy is not started at its full dose. The licensed schedule begins at 0.25mg once weekly, stepping up roughly every four weeks through 0.5mg, 1mg, 1.7mg, and finally 2.4mg, the standard maintenance dose. The higher 7.2mg dose, approved by the MHRA in early 2026, is an option for some patients and is titrated by a prescriber from that same starting point.

The step-up exists to reduce gastrointestinal side effects: nausea, loose stools, and indigestion are most common in the early weeks and at each dose increase, then tend to settle. This means that for the first month or two, appetite suppression is real but moderate. Dramatic weight loss in week one is not typical, and chasing it by skipping the titration would be unsafe.

The practical implication is patience. Many people find the noticeable shift in hunger starts around weeks two to four, with more consistent scale movement from around months two to four as the dose rises. If you want a closer look at when the effects of Wegovy begin to register, that page covers the early experience in more detail. The key point: the schedule is clinically designed, and the prescriber sets the pace based on how you are responding.

Does early weight loss predict how much you'll lose overall?

Broadly, yes, though the relationship is imperfect. Clinical guidance, including NICE's appraisal of semaglutide (TA875), notes that if a patient has not lost at least 5% of their body weight after six months at the maintenance dose, continuing treatment should be reviewed. That threshold is a clinical decision, not a self-administered one.

People who respond strongly in the first three months often continue to do well; those who see very little movement may need a prescriber to investigate why, whether that is a tolerability issue holding the dose down, dietary factors, or a question of whether a different treatment might suit them better. If you are comparing expected timelines across medicines, this breakdown of semaglutide weight-loss timelines gives a broader view.

Early movement matters for motivation too. A question our prescribers hear often is whether the first few weeks are representative. They rarely are. Give it time. The medicines work on appetite and satiety, changes in behaviour accumulate over months, not days.

What should you realistically expect in the first three months?

In practical terms: weeks one to four tend to bring reduced appetite and possibly two to four kilograms of weight loss, sometimes more, and our page on how quickly you start losing weight on Wegovy walks through what those early weeks typically look like. Months two and three, as the dose steps up, often see the most consistent weekly movement, and if you want a fuller picture of the overall trajectory, our guide to how quickly you see weight loss with Wegovy covers the longer-term pattern in detail. Nausea or digestive discomfort can interrupt progress temporarily, this usually settles, but it is worth telling your prescriber rather than stopping the medicine unilaterally.

For context on cost, the Wegovy cost page covers what private treatment typically involves financially, which is useful to factor in across a realistic multi-month timeline. Side effects, dose changes and life disruptions all affect the journey. The medicine is one part of the picture; eating habits, sleep, stress, and activity form the rest.

When your treatment arrives (in plain, unbranded packaging with DPD tracked delivery) the pen comes with a patient information leaflet that includes storage guidance and a breakdown of what to do if a dose is missed. Read it before your first injection. If anything changes clinically (new medication, surgery, pregnancy) contact your prescriber rather than relying on what you remember from onboarding. That's what aftercare is for.

If you're ready to find out whether Wegovy is clinically suitable for you, you can check your eligibility with a free consultation at any time.